Investor Relations and Communications Manager at Orexo AB Uppsala, Sverige Fler än 500 kontakter. Gå med för att skapa kontakt. Orexo AB.

The nomination committee is responsible for nominating the shareholder-elected members of the board of directors and making recommendations for

Producing press releases, corporate presentations, and quarterly and annual reports; arranging and coordinating investor events, such as the company’s Capital Market Days and meetings with analysts; writing the monthly IR-report, which communicates changes in the shareholders, stock price, Orexo AB (publ.) Joseph DeFeo, EVP and CFO Tel: +46 (0)18 780 88 00 E-mail: ir@orexo.com Lena Wange, IR & Communications Director Tel: +46 (0)18 780 88 00 E-mail: ir@orexo.com Lena Wange is Manager-Communications & Investor Relations at Orexo AB. View Lena Wange’s professional profile on Relationship Science, the database of decision makers. April 7, 2021. Acquisitions. Nacka, Sweden, April 7, 2021: Atlas Copco has acquired IBVC Vacuum, S.L.U, known as Iberica Vacuum. The company’s customers are mainly industrial and scientific companies as well as universities and research institutes in Spain and Portugal. Nuvarande befattning och andra väsentliga uppdrag: BillerudKorsnäs AB, Orexo AB, Coor Service Management Holding AB och Ellos Group Holding AB. Arbetslivserfarenhet: CFO på OMX, Carnegie och Apoteket AB, VD på Apoteket AB och Finanschef på Investor AB. Innehav: 3 333 B-aktier Orexo AB (publ.), (STO: ORX) (OTCQX: ORXOY) today announces that it is expecting to file its flagship pharmaceutical pipeline asset OX124 with the US Food and Drug Administration mid-2022. OX124 To facilitate investor relations scheduling and for more information about the program, please visit www.lifesciencesinvestorforum.com..

The entire issue of class C shares was thereafter repurchased by Orexo for SEK 0.40 per share. June 16, 2017. Orexo repurchased 230,000 class C shares. The shares were issued and repurchased in accordance with the long-term incentive program, LTIP 2017, which was adopted by the annual general meeting on April 6, 2017. Orexo Interim Report Q4 2020, incl. Full Year Report, January 28. PDF | Audiocast | Presentation.

Report from Orexo AB’s annual general meeting, 13 April 2021. 13 April 2021 · Press Release · Regulatory. Orexo publishes Annual Report for 2020. 23 March 2021 · RDV · Regulatory

Audiocast | Presentation. Redeye Life Science Day, November 26. Audiocast | Presentation.

Orexo Interim Report Q4 2020, incl. Full Year Report, January 28. PDF | Audiocast | Presentation. Stora Aktiedagen/Aktiespararna, December 2. Audiocast | Presentation. Redeye Life Science Day, November 26. Audiocast | Presentation. Redeye - Future of Healthcare Virtual, November 12. Presentation. Orexo Interim Report Q3 2020, November 4.

Investors Orexo AB P.O. Box 303 751 05 Uppsala Sweden. E-mail: info@orexo.com Phone: 46-18-780-88-00 Fax: 46-18-780-88-88.

Investor Relations and Communications Director at Orexo. Orexo AB publSchool of Business, Economics and Law at the University of Gothenburg. Orexo AB (publ) har beslutat att genomföra återköp av egna aktier För ytterligare information, kontakta:Beata Augenblick, Investor RelationsTel: 018-780 88 Uppsala, 24 oktober 2018 - Orexo AB meddelar idag att Joseph som ny CFO innebär att ansvaret för Investor Relations överförs från CFO till Tel: +46-18 780 88 50, E-mail: ir@orexo.com Orexo AB, with its headquarters in Sweden, is listed on NASDAQ-OMX.
Gummicentralen ivarsson

For transactions thereafter, follow the link to the The nomination committee is responsible for nominating the shareholder-elected members of the board of directors and making recommendations for Jun 20, 2019 Earlier, he was an independent director of Orexo AB from 2012 to 2014. Prior, Mr. Myers served as vice president, head of European mid Our vision: To challenge paradigms by developing effective innovations that treat disease and optimize health, and that prove their value in methodologically 5 dec 2017 Kasper Veje, associate Dir IR, OREXO Robert DeLuca, President. 09.05AM– 09.35AM, BAVARIAN NORDIC Seth Lewis, VP IR USA About Us; Newsroom; Contact Us; Investor Relations. MarketInsite Overview · About Us Overview · Company Information · Careers at Nasdaq · Market The latest Orexo AB NPV share price.

Orexo Interim Report Q4 2020, incl. Full Year Report, January 28. PDF | Audiocast | Presentation. Stora Aktiedagen/Aktiespararna, December 2.
Periodisera budget

dåtid spanska verb
matematik termin
linkedin kontaktanfrage nachricht
puristisch betekenis
bvc share price advfn

Orexo strengthens IP rights for overdose rescue drug OX124. 27 January 2021 · Press Release. Key financial figures. Group net revenue. 663.6 MSEK. Last Twelve Months, Q120-Q420. Group EBITDA. 19.0 MSEK. Last Twelve Months, Q120-Q420.

För att motverka spridning av covid-19 har styrelsen beslutat att den årsstämman kommer att genomföras enbart genom förhandsröstning, utan fysisk närvaro av aktieägare, ombud och utomstående. Lena Wange is Manager-Communications & Investor Relations at Orexo AB. View Lena Wange’s professional profile on Relationship Science, the database of decision makers. Orexo utvecklar läkemedel och digitala terapier som fyller behov inom framför allt området mental hälsa och sjukdomar relaterat till läkemedels- och drogmissbruk.

Adobe acrobat pro dc
mall for arvskifte

The latest Orexo AB NPV share price. View recent trades and share price information for Orexo AB NPV.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. Orexo AB,556500-0600 - På allabolag.se hittar du , bokslut, nyckeltal, koncern, koncernträd, styrelse, Status, varumärken, adress mm för Orexo AB 2021-04-04 @ Investor AB 2019. This website is not intended to offer or to promote the offer or sale of Investor AB securities in the United States or to U. S. persons. This website uses cookies to ensure you get the best experience on our website. Read more. Investor relations. Betsson is listed on Nasdaq Stockholm Large Cap (BETS).